Title:To Explore the Mechanism of Maiwei Dihuang Decoction in the Treatment
of Non-small Cell Lung Cancer based on Network Pharmacology Combined
with LC-MS
Volume: 20
Issue: 5
Author(s): Tao Jiang, Yang Lu, Wanzhi Yang, Jinhong Xu, Mingxing Zhu, Yong Huang, Fang Bao, Shengqi Zheng*Yongxia Li*
Affiliation:
- Department of Pharmacy, Navy Anqing Hospital, Anqing, Anhui Province, China
- Department of Pharmacy, Navy Anqing Hospital, Anqing, Anhui Province, China
Keywords:
Network pharmacology, LC-MS, molecular docking, non-small cell lung cancer, Maiwei Dihuang decoction, cancer signal pathway.
Abstract:
Objective: To explore the mechanism of Maiwei Dihuang decoction in the treatment of
non-small cell lung cancer (NSCLC) by using network pharmacology and LC-MS technology.
Methods: The effective components in Maiwei Dihuang decoction were detected by liquid chromatography-
mass spectrometry (LC-MS). Use the SuperPred database to collect the relevant targets
of the active ingredients of Mai Wei Di Tang, and then collect the relevant targets of nonsmall
cell lung cancer from GeneCards, DisgenNET and OMIM databases. On this basis, PPI
network construction, GO enrichment analysis and KEGG pathway annotation analysis were carried
out for target sites. Finally, AutoDock Vina is used for molecular docking.
Results: We further screened 16 effective Chinese herbal compounds through LC-MS combined
with ADME level. On this basis, we obtained 77 core targets through protein interaction network
analysis. Through GO, KEGG analysis and molecular docking results, we finally screened out the
potential targets of Maiwei Dihuang Decoction for NSCLC: TP53, STAT3, MAPK3.
Conclusion: Maiwei Dihuang decoction may play a role in the treatment of NSCLC by coregulating
TP53/STAT3/MAPK3 signal pathway.